Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1 | 6.2893081761 | 1.59 | 1.9 | 1.52 | 87094 | 1.69013404 | CS |
4 | -0.25 | -12.8865979381 | 1.94 | 2.04 | 1.43 | 88168 | 1.70544513 | CS |
12 | -0.76 | -31.0204081633 | 2.45 | 7.2 | 1.35 | 2676635 | 2.74267032 | CS |
26 | -3.03 | -64.1949152542 | 4.72 | 7.2 | 1.35 | 1275314 | 2.80680607 | CS |
52 | -5.11 | -75.1470588235 | 6.8 | 7.6 | 1.35 | 661565 | 2.88929942 | CS |
156 | -208.31 | -99.1952380952 | 210 | 240 | 1.35 | 483525 | 39.75107299 | CS |
260 | -1204.31 | -99.85986733 | 1206 | 1350 | 1.35 | 667390 | 183.83075957 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.